These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25886806)

  • 1. Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment.
    Yang CF; Meyerhoff RR; Stephens SJ; Singhapricha T; Toomey CB; Anderson KL; Kelsey C; Harpole D; D'Amico TA; Berry MF
    Ann Thorac Surg; 2015 Jun; 99(6):1914-20. PubMed ID: 25886806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.
    Shimada Y; Suzuki K; Okada M; Nakayama H; Ito H; Mitsudomi T; Saji H; Takamochi K; Kudo Y; Hattori A; Mimae T; Aokage K; Nishii T; Tsuboi M; Ikeda N
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):895-901. PubMed ID: 27543652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
    Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.
    Bauman JE; Mulligan MS; Martins RG; Kurland BF; Eaton KD; Wood DE
    Ann Thorac Surg; 2008 Nov; 86(5):1632-8; discussion 1638-9. PubMed ID: 19049763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer.
    Romero-Vielva L; Viteri S; Moya-Horno I; Toscas JI; Maestre-Alcácer JA; Ramón Y Cajal S; Rosell R
    Lung Cancer; 2019 Jul; 133():117-122. PubMed ID: 31200817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results.
    Park BJ; Melfi F; Mussi A; Maisonneuve P; Spaggiari L; Da Silva RK; Veronesi G
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):383-9. PubMed ID: 22104677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis.
    Urbanic JJ; Turrisi AT; Sharma AK; Silvestri GA; Williams TE; Vanek KN; Sherman CA
    J Thorac Oncol; 2006 Feb; 1(2):112-9. PubMed ID: 17409839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
    Ludwig C; Stoelben E; Olschewski M; Hasse J
    Ann Thorac Surg; 2005 Mar; 79(3):968-73. PubMed ID: 15734415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
    Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
    J Cardiothorac Surg; 2016 Jan; 11():9. PubMed ID: 26781697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.
    Rusch VW; Albain KS; Crowley JJ; Rice TW; Lonchyna V; McKenna R; Livingston RB; Griffin BR; Benfield JR
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):97-104; discussion 104-6. PubMed ID: 8380477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.
    Wang EH; Corso CD; Rutter CE; Park HS; Chen AB; Kim AW; Wilson LD; Decker RH; Yu JB
    J Clin Oncol; 2015 Sep; 33(25):2727-34. PubMed ID: 26101240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience.
    Kim D; Ferraris VA; Davenport D; Saha S
    South Med J; 2015 Apr; 108(4):230-4. PubMed ID: 25871994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer.
    Casiraghi M; Maisonneuve P; Piperno G; Bellini R; Brambilla D; Petrella F; Marinis F; Spaggiari L
    Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):233-241. PubMed ID: 28823336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer.
    Ross P; Grecula J; Bekaii-Saab T; Villalona-Calero M; Otterson G; Magro C
    Lasers Surg Med; 2006 Dec; 38(10):881-9. PubMed ID: 17115382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobectomy for non-small cell lung carcinoma: a nationwide study of short- and long-term survival.
    Oskarsdottir GN; Halldorsson H; Sigurdsson MI; Fridriksson BM; Baldvinsson K; Orrason AW; Jonsson S; Planck M; Gudbjartsson T
    Acta Oncol; 2017 Jul; 56(7):936-942. PubMed ID: 28325129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.
    Allen AM; Mentzer SJ; Yeap BY; Soto R; Baldini EH; Rabin MS; Sugarbaker DJ; Bueno R
    Cancer; 2008 Mar; 112(5):1106-13. PubMed ID: 18286507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.